This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Aetna Announces New Leadership In Government And International Businesses

Aetna (NYSE: AET) today announced new leadership in its Government and International businesses. Francis S. Soistman will lead Aetna Government Services and Richard di Benedetto will join the company as the head of Aetna International. Soistman and di Benedetto will report to Mark T. Bertolini, Aetna chairman, CEO and president, and will serve on the company’s Executive Committee.

“The Government and International marketplaces represent significant long-term growth opportunities for Aetna and we are pleased to add two strong leaders to these growing businesses,” said Bertolini. “Fran and Richard have a deep understanding of their respective marketplaces and the proven ability to drive sustainable growth.”

Soistman has been leading Aetna’s Medicare business, helping oversee the Medicare components of the Coventry Health Care acquisition as well as the 2014 Medicare bids for Aetna and Coventry. Prior to joining Aetna, Soistman was a co-founder of the health care management firm Jessamine Healthcare. He previously held leadership roles with Coventry Health Care, including head of the Individual Consumer and Government Business Division. Under his leadership, Coventry became one of the five largest Medicare Advantage and Part D plan sponsors in the nation. Soistman also served as senior vice president of Coventry Health Care and president and chief executive officer of HealthAmerica Pennsylvania, Inc. and HealthAssurance Pennsylvania, Inc.

Richard di Benedetto comes to Aetna from Euromedic International, where he served as CEO for one of the largest private medical services providers in Europe in the field of Diagnostics Services, Laboratories and Cancer Treatment. Euromedic operates 130 centers in 15 countries and employs more than 3,000 people. Prior to his role with Euromedic, di Benedetto spent 15 years with GE Healthcare. During his time with GE he held a variety of leadership roles with increasing responsibility, most recently serving as the president and CEO of its Eastern and Africa Growth Markets.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,011.94 -28.43 -0.16%
S&P 500 2,109.60 -2.13 -0.10%
NASDAQ 5,076.5240 -6.4050 -0.13%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs